Cargando…
Transcytosable Peptide-Paclitaxel Prodrug Nanoparticle for Targeted Treatment of Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) is an extremely aggressive subtype associated with a poor prognosis. At present, the treatment for TNBC mainly relies on surgery and traditional chemotherapy. As a key component in the standard treatment of TNBC, paclitaxel (PTX) effectively inhibits the growth a...
Autores principales: | Wang, Longkun, Zhao, Chunqian, Lu, Lu, Jiang, Honglei, Wang, Fengshan, Zhang, Xinke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003159/ https://www.ncbi.nlm.nih.gov/pubmed/36902076 http://dx.doi.org/10.3390/ijms24054646 |
Ejemplares similares
-
A Novel Blood–Brain Barrier-Penetrating and Vascular-Targeting Chimeric Peptide Inhibits Glioma Angiogenesis
por: Lu, Lu, et al.
Publicado: (2023) -
A Dual Receptor Targeting- and BBB Penetrating- Peptide Functionalized Polyethyleneimine Nanocomplex for Secretory Endostatin Gene Delivery to Malignant Glioma
por: Lu, Lu, et al.
Publicado: (2020) -
Prodrug Strategies for Paclitaxel
por: Meng, Ziyuan, et al.
Publicado: (2016) -
Enhanced bioreduction-responsive diselenide-based dimeric prodrug nanoparticles for triple negative breast cancer therapy
por: He, Xi, et al.
Publicado: (2018) -
Antinociceptive Effects of Transcytosed Botulinum Neurotoxin Type A on Trigeminal Nociception in Rats
por: Kim, Hye-Jin, et al.
Publicado: (2015)